HYPERKALEMIA RISK COMPARISON IN PATIENTS ON VALSARTAN/SACUBITRIL: NORMAL RENAL PROFILE VERSUS ADVANCED CHRONIC KIDNEY DISEASE. RMSR. 2025;3(5):1163-1167. Accessed August 7, 2025. https://medscireview.net/index.php/Journal/article/view/1597